ArticleClinical Medicine Insights. Oncology2018

Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience.

B J Srinivasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.